Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Valerio, Maria Rosaria
HERMIONE-7, NCT04227327: Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients	Active, not recruiting	2	31	Europe	Abemaciclib, Aromatase Inhibitors	University of Milano Bicocca	Advanced Breast Cancer	12/23	12/23
HERMIONE-10, NCT05302778: Eribulin as a Second-line Treatment in Triple-negative Advanced Breast Cancer	Recruiting	N/A	200	Europe		University of Milano Bicocca, EISAI s.r.l.	Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer	12/23	12/23